Screener
Gyre Therapeutics, Inc. GYRE Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $1,236 | $1,335 |
| Due to related parties | 5,085 | 227 |
| Accrued expenses and other current liabilities | 18,810 | 18,161 |
| Income tax payable | 2,147 | 2,940 |
| Operating lease liabilities, current | 1,385 | 1,119 |
| Total current liabilities | 28,663 | 23,782 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Gyre Therapeutics, Inc.'s accrued expenses?
- Gyre Therapeutics, Inc. (GYRE) reported accrued expenses of $5.09M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s accrued expenses changed year-over-year?
- Gyre Therapeutics, Inc.'s accrued expenses increased by 2221.9% year-over-year, from $219K to $5.09M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s accrued expenses has grown at a -49.3% compound annual growth rate (CAGR), from $6.74M to $227K.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Gyre Therapeutics, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude